Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | NT5E | P21589 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22985067 | 0.95 | KIF11 (0.33) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL22985619 | 0.93 | ALOX5AP (0.34) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL22985613 | 0.93 | ALOX5AP (0.34) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL22985072 | 0.93 | AR (0.37) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL22985074 | 0.91 | DDR1 (0.32) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL20848873 | 0.90 | ELANE (0.34) | PTGDR2KIF11ELANE | |
| SCHEMBL22985128 | 0.90 | ALOX5AP (0.33) | TSHRSMN1; SMN2PTGDR2SCN9AKIF11 | |
| SCHEMBL22985130 | 0.90 | AR (0.33) | TSHRSMN1; SMN2SCN9AKIF11ALOX5AP | |
| SCHEMBL22985139 | 0.89 | ALOX5AP (0.33) | TSHRSMN1; SMN2PTGDR2KIF11ALOX5AP | |
| SCHEMBL22985066 | 0.89 | AR (0.34) | KIF11ALOX5APFEN1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | TSHR 3378/4885SMN1; SMN2 3496/4885PTGDR2 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.